Caveat Emptor: The Perils of Panel Testing in Hereditary Breast Cancer

Affiliations

¹ Amy Taylor, PhD, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; and Marc Tischkowitz, MD, PhD, Cambridge University Hospitals National Health Service Trust and University of Cambridge, Cambridge, United Kingdom.

Comment

Amy Taylor et al. J Clin Oncol. 2019.

. 2019 Aug 20;37(24):2176-2177.

doi: 10.1200/JCO.19.00122. Epub 2019 Jun 27.

¹ Amy Taylor, PhD, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; and Marc Tischkowitz, MD, PhD, Cambridge University Hospitals National Health Service Trust and University of Cambridge, Cambridge, United Kingdom.

No abstract available

Comment in

Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al.
Beitsch P, Hughes K, Whitworth P. Beitsch P, et al. J Clin Oncol. 2019 Aug 20;37(24):2178-2180. doi: 10.1200/JCO.19.00798. Epub 2019 Jun 27. J Clin Oncol. 2019. PMID: 31246521 No abstract available.

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, Kinney M, Coomer C, Barbosa K, Holmes DR, Brown E, Gold L, Clark P, Riley L, Lyons S, Ruiz A, Kahn S, MacDonald H, Curcio L, Hardwick MK, Yang S, Esplin ED, Nussbaum RL. Beitsch PD, et al. J Clin Oncol. 2019 Feb 20;37(6):453-460. doi: 10.1200/JCO.18.01631. Epub 2018 Dec 7. J Clin Oncol. 2019. PMID: 30526229 Free PMC article.